Table 5 Pain definition, intensity and characteristics of included studies
Study | WAD | NSNP | Pain presence in months (SD) | Pain present at time of trial | Pain intensity evaluation (pre-trial) | Score mean (SD) |
|---|---|---|---|---|---|---|
McPartland et al. [18] | X | - | yes | - | - | |
Michaelson et al. [21] | X | 87 (77) | yes | VAS | 4.9 (2.3) | |
X | 97 (68) | yes | VAS | 5.2 (1.6) | ||
Madeleine et al. [23] | X | ≥ 6 | yes | NRS-11 | 6.0 (0.7) | |
X | induced | yes | NRS-11 | 2.6-4.5 (0.5) | ||
Treleaven et al. [19] | X | - | yes | VAS | 2.8 | |
X | - | yes | VAS | 4.1 | ||
Storaci et al. [26] | X | - | - | - | - | |
Endo et al. [25] | X | 6 | yes | - | - | |
Treleaven et al. [27] | X | 17 | yes | - | - | |
Field et al. [22] | X | ≥ 3 | yes | VAS | 2.2 (0.9) | |
X | ≥ 3 | yes | VAS | 3.2 (0.4) | ||
Poole et al. [24] | X | > 5 | yes | VAS | - | |
Vuillerme et al. [20] | X | induced | yes | VAS | 7.1 (1.7) |